Actively Recruiting

Phase Not Applicable
Age: 0 - 1Day
All Genders
Healthy Volunteers
NCT06727877

Predictive Diagnosis of Ulcero-Necrotizing EnteroColitis in Premature Babies Using an Artificial Intelligence Approach Based on Early Analysis of the Fecal Microbiota

Led by University Hospital, Clermont-Ferrand · Updated on 2026-04-06

1000

Participants Needed

5

Research Sites

113 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Prematurity affects around 7% of births in France. Necrotizing enterocolitis (NEC) is a dreaded digestive complication. It is responsible for a mortality rate ranging from 15 to 40%, a rate that has remained stable in recent years, and for medium- and long-term digestive and neurodevelopmental morbidity. Its onset is unpredictable and sudden, usually between 10 and 20 days of life, and requires immediate, aggressive management: hemodynamic support, fasting, systemic antibiotic therapy or even surgery. Prevention is therefore essential, but systematic measures with proven efficacy (breastfeeding, early enteral feeding, multiple probiotics) are few and far between. What's more, these preventive measures cannot be modulated and adapted individually, since it is not possible to finely predict the risk of developing enterocolitis. Thus, the use of a predictive diagnostic test for NEC would make it possible to identify high-risk premature babies and develop personalized preventive measures. Changes in the digestive microbiota precede the onset of NEC, but it has not been possible to identify a reproducible and reliable microbial signature. As a result, the limited power of microbiota analysis and interpretation means that it cannot be used in practice to predict ECUN. Our partner team (MEDiS) has developed a bioinformatics chain (RiboTaxa) to obtain the precise structure of complex microbial communities from direct metagenomic sequencing data. Stool samples from international cohorts (1562 samples, 208 preterm infants) were then mined to train a deep neural network and generate a predictive diagnostic test for NEC. In a local study (10 cases and 10 controls), the predictive diagnostic performance of this test was 90%, with the 1ère stool identified as "at risk" preceding NEC by 8 days (extremes 4 - 17 days), and the 2nde by 2 days (extremes 0-7 days). We would now like to test our predictive diagnostic technique on a larger number of premature babies in the AURA region. 1000 children included, 200 children tested (50 NEC - 150 controls)

CONDITIONS

Official Title

Predictive Diagnosis of Ulcero-Necrotizing EnteroColitis in Premature Babies Using an Artificial Intelligence Approach Based on Early Analysis of the Fecal Microbiota

Who Can Participate

Age: 0 - 1Day
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Child born prematurely before 34 weeks of pregnancy in a participating university hospital and cared for in a neonatal intensive care unit in the AURA region
  • Child born outside a participating hospital but transferred within 24 hours to a participating neonatal intensive care unit
  • Child is covered by a Social Security health insurance plan
Not Eligible

You will not qualify if you...

  • Child whose guardians have legal protection such as guardianship, curatorship, or legal safeguard
  • Child whose parents are under 18 years old
  • Parents or guardians refuse permission for participation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 5 locations

1

CHU de Clermont-Ferrand

Clermont-Ferrand, France

Actively Recruiting

2

CHU Grenoble

Grenoble, France

Not Yet Recruiting

3

HFME

Lyon, France

Not Yet Recruiting

4

Hopital Croix Rousse

Lyon, France

Not Yet Recruiting

5

CHU Saint Etienne

Saint-Etienne, France

Actively Recruiting

Loading map...

Research Team

L

Lise Laclautre

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

DIAGNOSTIC

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here